Evidence map›Paper›PMID 30302231›Full record

ArticleInternational journal of hematologic oncology2017

Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH.

Elie El Rassy, Alain Chebly, Rima Korban, Warde Semaan, Ziad Bakouny, Tarek Assi, Hampig Raphael Kourie, Fadi El Karak, Eliane Chouery, Joseph Kattan

Abstract read
In one paragraph

Article in International journal of hematologic oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elie El RassyDepartment of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Alain CheblyDepartment of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Rima KorbanDepartment of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Warde SemaanDepartment of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Ziad BakounyDepartment of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Tarek AssiDepartment of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Hampig Raphael KourieDepartment of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Fadi El KarakDepartment of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Eliane ChoueryDepartment of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.
Joseph KattanDepartment of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe aimed to understand the biology of chronic lymphocytic leukemia (CLL) patients in Lebanon. MATERIALS &

methodsWe applied conventional cytogenetic and FISH studies on Lebanese patients diagnosed with CLL and undergoing a watch and wait approach.

resultsOur study disclosed 53.6% of patients with aberrant karyotypes among which 26.7% were complex karyotypes. Genetic aberrations included del(13q14) 46.4%, 14q32 translocation in 25%, trisomy 12 in 14.3%, del(17p13) and del(11q22) in 7.1% each. The deletion of 6q21/6q23 was not found in any of our patients.

conclusionThe higher prevalence of del(13q14) as a sole abnormality could be the primary event in inducing CLL. The del(17p13) and del(11q22) followed as potential drivers for progression in CLL patients with a watch and wait approach.

Indexed as

chronic lymphocytic leukemiafluorescence in situ hybridizationMiddle Eastmolecular characteristicssmall lymphocytic lymphoma

Identifiers

PMID30302231
PMCPMC6172003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.